Exploring ageing as a potential new therapeutic target for schizophrenia.
Where this comes from
- Record sourced from PubMed, PMID 42504106.
- Also identified by DOI 10.1192/bjp.2026.10746.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Increased age-related biological changes have been causally linked to various pathologies in the brain, including Alzheimer's and Parkinson's diseases. There is also evidence that schizophrenia could be included in this group of brain disorders that may actually be manifestations of a broader multisystemic premature ageing phenotype.